Showing results (51-60 of 77) with videos related to
Sort By:
Pageof 8
Nature Reviews. Cardiology|February 19, 2026
Invasive and medical management approaches to non-acute myocardial ischaemic syndromesNicholas Chiu, Deepak L Bhatt, Raffaele De Caterina, et al.Journal of the American College of Cardiology|September 5, 2015
Long-Term Outcomes in Patients With Diabetes Mellitus Related to Prolonging Clopidogrel More Than 12 Months After Coronary StentingArun K Thukkani, Kush Agrawal, Lillian Prince, et al.Journal of the American College of Cardiology|October 30, 2007
Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the OASIS-5 trialShamir R Mehta, Christopher B Granger, John W Eikelboom, et al.Circulation|January 13, 2006
Payment for quality: guiding principles and recommendations: principles and recommendations from the American Heart Association's Reimbursement, Coverage, and Access Policy Development WorkgroupVincent Bufalino, Eric D Peterson, Gregory L Burke, et al.Pediatric Cardiology|August 20, 2025
Comparison of Arrhythmia Prevalence and Incidence in Adult Patients with Lateral Tunnel and Extra-Cardiac Fontan CirculationAndrew M Freddo, Antara Mondal, Alexis Z Tomlinson, et al.JACC. Advances|August 21, 2025
Cardiac Medication Prescription Pattern and Association With Transplant-free Survival in the Adult Fontan PopulationAndrew M Freddo, Molly Eron, Antara Mondal, et al.Journal of the American Heart Association|November 5, 2017
Double-Dose Versus Standard-Dose Clopidogrel According to Smoking Status Among Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary InterventionMatthias Bossard, Christopher B Granger, Jean-Francois Tanguay, et al.The American Journal of Cardiology|June 7, 2017
Usefulness of Intracoronary Brachytherapy for Patients With Resistant Drug-Eluting Stent RestenosisFernanda M Mangione, Tannas Jatene, Roza Badr Eslam, et al.Journal of the American College of Cardiology|July 25, 2009
Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes treated with glycoprotein IIb/IIIa inhibitors or thienopyridines: results from the OASIS 5 (Fifth Organization to Assess Strategies in Ischemic Syndromes) trialSanjit S Jolly, David P Faxon, Keith A A Fox, et al.Journal of the American College of Cardiology|July 6, 2019
Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI: JACC State-of-the-Art ReviewDavide Capodanno, Kurt Huber, Roxana Mehran, et al.Pageof 8